XOMA Financial Statements
XOMA Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
XOMA Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 68.0 | 84.3 | 29.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (38.0) | (0.7) | (38.9) |
| Total Net Income ($ mil.) | (45.2) | (12.3) | (51.8) |
| Diluted EPS (Net Income) | (0.34) | (0.10) | (0.54) |
XOMA Quarterly Statements
| Quarter Ending Jun 09 | Quarter Ending Mar 09 | Quarter Ending Dec 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 9.7 | 39.7 | 36.9 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (8.6) | 13.8 | -- |
| Total Net Income ($ mil.) | (10.2) | 6.2 | 10.0 |
| Diluted EPS (Net Income) | (0.07) | 0.04 | 0.08 |
XOMA Stock Quote & Chart
11/06/09 15:59:58 EST •
NASDAQ •
0.76
•
 +0.0220
•
+2.9730 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
XOMA Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.13 | 7.55 | 7.01 |
| Price/Earnings Ratio | (7.42) | 93.46 | 25.51 |
| Price/Book Ratio | (6.84) | 3.48 | 6.74 |
| Price/Cash Flow Ratio | (20.83) | 41.49 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed XOMA Financial Ratios
XOMA Competitive Intelligence
| Abbott Labs | Amgen | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 29,527.6 | 15,003.0 | 48,296.0 |
| Employees | 69,000 | 16,900 | 81,800 |
| Market Cap ($ mil.) | 79,660.8 | 55,536.4 | 136,859.3 |
Competitive Landscape
